Singapore markets closed

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1600-0.0500 (-1.19%)
At close: 04:00PM EDT
4.0900 -0.07 (-1.68%)
After hours: 07:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 250.13M
Enterprise value 122.97M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.09
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.49

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-60.51%
S&P500 52-week change 322.38%
52-week high 311.9700
52-week low 31.4200
50-day moving average 33.6918
200-day moving average 34.3685

Share statistics

Avg vol (3-month) 3576.4k
Avg vol (10-day) 3410.27k
Shares outstanding 559.41M
Implied shares outstanding 660.13M
Float 843.16M
% held by insiders 11.99%
% held by institutions 161.57%
Shares short (15 Apr 2024) 42.36M
Short ratio (15 Apr 2024) 43.08
Short % of float (15 Apr 2024) 44.79%
Short % of shares outstanding (15 Apr 2024) 43.97%
Shares short (prior month 15 Mar 2024) 41.83M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-14.29%
Return on equity (ttm)-23.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -35.13M
Net income avi to common (ttm)-30.01M
Diluted EPS (ttm)-0.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)133.04M
Total cash per share (mrq)2.24
Total debt (mrq)15.66M
Total debt/equity (mrq)13.81%
Current ratio (mrq)6.50
Book value per share (mrq)1.91

Cash flow statement

Operating cash flow (ttm)-30.85M
Levered free cash flow (ttm)-30.86M